1. Home
  2. FULC vs ODV Comparison

FULC vs ODV Comparison

Compare FULC & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • ODV
  • Stock Information
  • Founded
  • FULC 2015
  • ODV 2005
  • Country
  • FULC United States
  • ODV Canada
  • Employees
  • FULC N/A
  • ODV N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • ODV Precious Metals
  • Sector
  • FULC Health Care
  • ODV Basic Materials
  • Exchange
  • FULC Nasdaq
  • ODV Nasdaq
  • Market Cap
  • FULC 210.9M
  • ODV 239.0M
  • IPO Year
  • FULC 2019
  • ODV N/A
  • Fundamental
  • Price
  • FULC $3.85
  • ODV $1.44
  • Analyst Decision
  • FULC Hold
  • ODV
  • Analyst Count
  • FULC 9
  • ODV 0
  • Target Price
  • FULC $7.63
  • ODV N/A
  • AVG Volume (30 Days)
  • FULC 368.1K
  • ODV 163.3K
  • Earning Date
  • FULC 02-25-2025
  • ODV 03-28-2025
  • Dividend Yield
  • FULC N/A
  • ODV N/A
  • EPS Growth
  • FULC N/A
  • ODV N/A
  • EPS
  • FULC N/A
  • ODV N/A
  • Revenue
  • FULC $80,871,000.00
  • ODV $8,487,361.00
  • Revenue This Year
  • FULC $2,823.78
  • ODV N/A
  • Revenue Next Year
  • FULC N/A
  • ODV $479.40
  • P/E Ratio
  • FULC N/A
  • ODV N/A
  • Revenue Growth
  • FULC 2987.86
  • ODV N/A
  • 52 Week Low
  • FULC $2.86
  • ODV $1.34
  • 52 Week High
  • FULC $13.70
  • ODV $2.75
  • Technical
  • Relative Strength Index (RSI)
  • FULC 47.75
  • ODV 39.96
  • Support Level
  • FULC $3.64
  • ODV $1.37
  • Resistance Level
  • FULC $3.94
  • ODV $1.48
  • Average True Range (ATR)
  • FULC 0.18
  • ODV 0.08
  • MACD
  • FULC 0.02
  • ODV -0.00
  • Stochastic Oscillator
  • FULC 84.21
  • ODV 30.57

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation and development activities of its projects.

Share on Social Networks: